Zota Health Care (NSE:ZOTA) Beneish M-Score: -1.20 (As of Jun. 27, 2026)


NSE:ZOTA Zota Health Care Ltd NSE:ZOTA
77 GF Score
Price ₹1,389.50
GF Value ₹1,568.77
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Zota Health Care Beneish M-Score?

Zota Health Care NSE:ZOTA +0.35% 77 Beneish M-Score is -1.20 as of Jun. 27, 2026. GuruFocus rates NSE:ZOTA with a GF Score™ of 77/100 and a GF Value™ of ₹1,568.77 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 831 Biotechnology companies, Zota Health Care ranks worse than 76.17% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.2 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Zota Health Care's Beneish M-Score or its related term are showing as below:

NSE:ZOTA' s Beneish M-Score Range Over the Past 10 Years
Min: -3.45   Med: -2.15   Max: 1.86
Current: -1.2

During the past 13 years, the highest Beneish M-Score of Zota Health Care was 1.86. The lowest was -3.45. And the median was -2.15.


Zota Health Care Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Zota Health Care's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zota Health Care Beneish M-Score Chart

Zota Health Care Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.13 -3.45 -2.58 -1.60 -1.20

Zota Health Care Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.60 0.00 0.00 0.00 -1.20

NSE:ZOTA vs VRTX, REGN, ALNY: Beneish M-Score Comparison

For the Biotechnology subindustry, Zota Health Care's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zota Health Care Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zota Health Care's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Zota Health Care's Beneish M-Score falls into.


NSE:ZOTA
77GF Score
Zota Health Care Ltd NSE:ZOTA
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zota Health Care Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Zota Health Care for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0113+0.528 * 0.8815+0.404 * 1.7544+0.892 * 1.8386+0.115 * 1.0219
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * 0.009274-0.327 * 0.7968
=-1.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹1,104 Mil.
Revenue was ₹5,387 Mil.
Gross Profit was ₹3,247 Mil.
Total Current Assets was ₹4,572 Mil.
Total Assets was ₹11,311 Mil.
Property, Plant and Equipment(Net PPE) was ₹3,665 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹825 Mil.
Selling, General, & Admin. Expense(SGA) was ₹0 Mil.
Total Current Liabilities was ₹2,373 Mil.
Long-Term Debt & Capital Lease Obligation was ₹1,899 Mil.
Net Income was ₹-739 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹-844 Mil.
Total Receivables was ₹594 Mil.
Revenue was ₹2,930 Mil.
Gross Profit was ₹1,557 Mil.
Total Current Assets was ₹1,842 Mil.
Total Assets was ₹4,391 Mil.
Property, Plant and Equipment(Net PPE) was ₹1,869 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹432 Mil.
Selling, General, & Admin. Expense(SGA) was ₹652 Mil.
Total Current Liabilities was ₹1,006 Mil.
Long-Term Debt & Capital Lease Obligation was ₹1,075 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1104.474 / 5386.575) / (593.992 / 2929.748)
=0.205042 / 0.202745
=1.0113

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1556.715 / 2929.748) / (3246.89 / 5386.575)
=0.531348 / 0.602774
=0.8815

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (4571.655 + 3664.816) / 11310.514) / (1 - (1841.626 + 1869.462) / 4391.405)
=0.271786 / 0.15492
=1.7544

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=5386.575 / 2929.748
=1.8386

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(431.961 / (431.961 + 1869.462)) / (824.531 / (824.531 + 3664.816))
=0.187693 / 0.183664
=1.0219

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 5386.575) / (652.255 / 2929.748)
=0 / 0.222632
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1899.488 + 2372.728) / 11310.514) / ((1075.497 + 1006.138) / 4391.405)
=0.377721 / 0.474025
=0.7968

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-739.361 - 0 - -844.254) / 11310.514
=0.009274

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Zota Health Care has a M-score of -1.20 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.20 mean?
Zota Health Care (NSE:ZOTA) has a Beneish M-Score of -1.20 as of Jun. 27, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Zota Health Care and its competitors. According to the industry distribution chart, Zota Health Care ranks #633 out of 831 companies in the Biotechnology industry, placing it in the top 76.2%.
Is Zota Health Care's Beneish M-Score too high?
Zota Health Care's current Beneish M-Score is -1.20. Based on the distribution chart, Zota Health Care ranks #633 out of 831 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Zota Health Care has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zota Health Care's Beneish M-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Zota Health Care ranks #633 out of 831 companies for Beneish M-Score. This places Zota Health Care in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Zota Health Care and its competitors. Zota Health Care's current Beneish M-Score is -1.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zota Health Care stock overvalued right now?
Based on GuruFocus' analysis, Zota Health Care (NSE:ZOTA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,568.77, compared to a current price of ₹1,389.50 — trading 11.4% below its estimated fair value. The current Beneish M-Score is -1.20. Zota Health Care's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Zota Health Care (NSE:ZOTA), the current Beneish M-Score is -1.20 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zota Health Care (NSE:ZOTA) Overvalued in 2026?

Based on GuruFocus' analysis, Zota Health Care stock appears to be undervalued. The current stock price of ₹1,389.50 is trading 11.4% below its estimated GF Value™ of ₹1,568.77. GuruFocus considers Zota Health Care to be Modestly Undervalued.

Key valuation signals for NSE:ZOTA:

  • Beneish M-Score: -1.20
  • GF Value™: ₹1,568.77 vs. price of ₹1,389.50 (11.4% below fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the NSE:ZOTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zota Health Care Business Description

Address 2/896, Hira Modi Street, Zota House, Sagrampura, Surat, GJ, IND, 395002
Zota Health Care Ltd is engaged in the manufacturing, trading, and export of pharmaceutical products. The company caters to both domestic and international markets. It offers a vast range of pharmaceutical, nutraceutical, ayurvedic, and OTC products in India and overseas as well.
77GF Score

Get the complete analysis for NSE:ZOTA

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,389.50
Price
₹1,568.77
GF Value